Literature DB >> 21997393

Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.

Susan E Quaggin, Alfred L George.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997393     DOI: 10.1681/ASN.2011090932

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

1.  Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Authors:  Elaine Ku; Michael S Lipkowitz; Lawrence J Appel; Afshin Parsa; Jennifer Gassman; David V Glidden; Miroslaw Smogorzewski; Chi-Yuan Hsu
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

2.  Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.

Authors:  Xiqian Lan; Hongxiu Wen; Moin A Saleem; Joanna Mikulak; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2015-03-18       Impact factor: 3.362

3.  Protein domains of APOL1 and its risk variants.

Authors:  Xiqian Lan; Hongxiu Wen; Rivka Lederman; Ashwani Malhotra; Joanna Mikulak; Waldemar Popik; Karl Skorecki; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2015-06-17       Impact factor: 3.362

4.  KIDNEY DISEASE GENETICS AND THE IMPORTANCE OF DIVERSITY IN PRECISION MEDICINE.

Authors:  Jessica N Cooke Bailey; Sarah Wilson; Kristin Brown-Gentry; Robert Goodloe; Dana C Crawford
Journal:  Pac Symp Biocomput       Date:  2016

5.  APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.

Authors:  Xiqian Lan; Aakash Jhaveri; Kang Cheng; Hongxiu Wen; Moin A Saleem; Peter W Mathieson; Joanna Mikulak; Sharon Aviram; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-04

Review 6.  Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.

Authors:  Chien-An A Hu; Edward I Klopfer; Patricio E Ray
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

Review 7.  A focus on the association of Apol1 with kidney disease in children.

Authors:  Pepe M Ekulu; Agathe B Nkoy; Oyindamola C Adebayo; Orly K Kazadi; Michel N Aloni; Fanny O Arcolino; Rene M Ngiyulu; Jean-Lambert E Gini; François B Lepira; Lamberthus P Van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2020-04-06       Impact factor: 3.714

Review 8.  Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).

Authors:  Xiqian Lan; T K S Rao; Praveen N Chander; Karl Skorecki; Pravin C Singhal
Journal:  Front Microbiol       Date:  2015-06-09       Impact factor: 5.640

9.  Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Teresa K Chen; Ronit Katz; Michelle M Estrella; Orlando M Gutierrez; Holly Kramer; Wendy S Post; Michael G Shlipak; Christina L Wassel; Carmen A Peralta
Journal:  J Am Heart Assoc       Date:  2017-12-21       Impact factor: 5.501

10.  APOL1 Risk Genotypes Are Associated With Early Kidney Damage in Children in Sub-Saharan Africa.

Authors:  Pepe M Ekulu; Agathe B Nkoy; Dieumerci K Betukumesu; Michel N Aloni; Jean Robert R Makulo; Ernest K Sumaili; Eric M Mafuta; Mohamed A Elmonem; Fanny O Arcolino; Faustin N Kitetele; François B Lepira; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Kidney Int Rep       Date:  2019-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.